CONMED CorporationCNMDNYSE
LOADING
|||
Switch Symbol:
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | 7.18% |
| Q3 2025 | -1.68% |
| Q2 2025 | 9.20% |
| Q1 2025 | -1.74% |
| Q4 2024 | -2.82% |
| Q3 2024 | -3.83% |
| Q2 2024 | 3.71% |
| Q1 2024 | -3.09% |
| Q4 2023 | 12.55% |
| Q3 2023 | -8.16% |
| Q2 2023 | 8.24% |
| Q1 2023 | 2.61% |
| Q4 2022 | -4.28% |
| Q3 2022 | 11.09% |
| Q2 2022 | 7.69% |
| Q1 2022 | -6.07% |
| Q4 2021 | 4.63% |
| Q3 2021 | -4.06% |
| Q2 2021 | 12.88% |
| Q1 2021 | -14.42% |
| Q4 2020 | 17.92% |
| Q3 2020 | 14.21% |
| Q2 2020 | -14.03% |
| Q1 2020 | -16.32% |
| Q4 2019 | 10.10% |
| Q3 2019 | -6.95% |
| Q2 2019 | 11.64% |
| Q1 2019 | 1.97% |
| Q4 2018 | -26.56% |
| Q3 2018 | 41.43% |
| Q2 2018 | 29.49% |
| Q1 2018 | -7.96% |
| Q4 2017 | 1.31% |
| Q3 2017 | 2.85% |
| Q2 2017 | 5.55% |
| Q1 2017 | -0.21% |
| Q4 2016 | -8.61% |
| Q3 2016 | 4.30% |
| Q2 2016 | -3.02% |
| Q1 2016 | 22.50% |